fashion -WSS

fashion

author：hotspot 2025-09-28 16:35:21 - browse：5

Three boxes of Breyanzi on a dark blue background — biotech coverage from STAT — The FDA is looking into adverse events involving a number of CAR-T therapies, including Breyanzi. Illustration: STAT; Source: Business Wire

The Food and Drug Administration said Tuesday that it is investigating whether CAR-T therapy, which uses genetically modified white blood cells to attack tumors, can in rare cases cause lymphoma, a blood cancer.

“Although the overall benefits of these products continue to outweigh their potential risks for their approved uses, FDA is investigating the identified risk of T cell malignancy with serious outcomes, including hospitalization and death, and is evaluating the need for regulatory action,” the agency said in a statement.

The agency noted that it is investigating reports of T cell lymphoma, including cancer cells carrying the engineered T cells, in patients who received CAR-T therapy. Experts in the field, which has produced multiple approved products to treat blood cancer, expressed surprise and puzzlement at the announcement, saying that they had not previously seen data about the risk.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Novavax promises a turnaround & Lilly roils the obesity market
Next article： Medicare’s new pay boost for primary care is angering specialists

WSS

Medical school prerequisites are outdated

Use doctors trained outside the U.S. to ease the physician shortage

Experimental asthma app from Apple and Anthem shows promise

Weight loss drugs should be covered by insurers, AMA says

Readout Newsletter: Zepbound, Valneva's vaccine, and more

Readout Newsletter: Novo Nordisk trial, Verve base editing, etc

hotspot

fashion

explore

Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies

After decades in use, heart stents finally beat placebo

BioMarin wins approval for gene therapy to treat hemophilia A

Archived: an online chat discussing Ebola, vaccines, and a new epidemic

Affirmative action in medical school literally saved lives

Dexcom's push to bring CGM to type 2 diabetes patients

Jerome Adams on the need for new antivirals for Covid

Readout Newsletter: Ozempic panic wanes, Legend x Novartis, etc.

Medicare proposal to cover medical devices draws a mixed reaction

Experimental asthma app from Apple and Anthem shows promise

explore

What health policies could hitch a ride on a spending bill?

Being 'nonadherent' patient made me a more empathetic doctor

Hubble vs. James Webb telescope images: See the difference

Crowdfunding for unproven stem cell procedures spreads misinformation

Readout Newsletter: Novo Nordisk trial, Verve base editing, etc

Being 'nonadherent' patient made me a more empathetic doctor

entertainment

focus

entertainment

focus